PMID: 22567825May 10, 2012Paper

HIV/HCV coinfection: a new era of treatment

BETA Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation
Liz Highleyman

Abstract

Hepatitis C is a life-threatening illness that can progress to cirrhosis, liver cancer, and end-stage liver failure. An estimated one-third of HIV positive people are coinfected with hepatitis C virus (HCV), and HCV-related liver disease is a major cause of death for people with HIV in the era of effective antiretroviral therapy (ART). HCV has made headlines recently due to the approval of the first direct-acting antiviral (DAA) agents, which promise to revolutionize hepatitis C treatment. Researchers at the 2011 Conference on Retroviruses and Opportunistic Infections (CROI) and the Infectious Disease Society of America (IDSA) annual meeting presented the first data from studies of these drugs in HIV/HCV coinfected people.

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.